Skip to content

Diabetes Update 2022: Program Evaluation - Saturday, April 30th

Your feedback provides us with vital information that assists in the development of future educational initiatives.
Assessment of Learning Objectives

Using a scale of poor to excellent, please indicate your level of confidence in the learning objective as it relates to your knowledge, belief, or behavior, pre-program and post-program.
Fatty Liver Disease and NASH | Giada Sebastiani, MD

Your knowledge of the underlying mechanisms and the risk of developing liver disease and nonalcoholic steatohepatitis (NASH) in patients with diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Your knowledge of the emerging diagnostic tools and therapeutics for fatty liver disease and NASH:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Technology Update | Alanna Weisman, MD

Your knowledge of new and emerging technologies in glucose monitoring and insulin delivery for type 1 and type 2 diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Exercise and Type 1 Diabetes | Jane Yardley, PhD

Your knowledge of the effectiveness and safety of high-intensity interval training (HIIT) in patients with type 1 diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Your knowledge of the rationale and evidence of HIIT vs. continuous aerobic trainings on blood glucose level:
Poor
Fair
Good
Very Good
Excellent
Before
After
Your knowledge of current evidence and guidelines on continuous glucose monitoring (CGM) for the interpretation and management of blood glucose during exercise:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Update on Dyslipidemia | George Thanassoulis, MD

Your knowledge of the 2021 CCS Dyslipidemia Guidelines and key recommendations for people living with diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Remission in Type 2 Diabetes | Zubin Punthakee, MD

Your knowledge of the definition of type 2 diabetes remission:
Poor
Fair
Good
Very Good
Excellent
Before
After
Your knowledge of the REMIT study and implications for people with a recent diagnosis of type 2 diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Current and Future Approaches to Type 1 Diabetes: Beyond Insulin and Technology | Peter Senior, MD

Your knowledge of the latest clinical trials and data for the prevention of type 1 diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Your knowledge of emerging treatments and therapies beyond insulin for the management of patients with type 1 diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Debate: Use of SGLT2is in Hospital | Jacob A. Udell, MD and Shelley Zieroth, MD

Your knowledge of pros and cons for the use of SGLT2is in patients hospitalized with heart failure with or without diabetes:
Poor
Fair
Good
Very Good
Excellent
Before
After
Your knowledge of the potential outcomes associated with the use of SGLT2is during hospitalization:
Poor
Fair
Good
Very Good
Excellent
Before
After
Effectiveness of Speaker - Dr. Jacob A. Udell:
Poor
Fair
Good
Very Good
Excellent
Effectiveness of Speaker - Dr. Shelley Zieroth:
Poor
Fair
Good
Very Good
Excellent
Additional comments:
Additional Feedback 
2. From what you have learned, how will this impact / modify your practice and what will you be able to apply to your practice? What potential barriers do you anticipate and how will you overcome them?
Please indicate which CanMEDS roles you felt were addressed during this educational activity?
Sessions allocated at least 25% of the time for interaction
Did you perceive any sources of commercial bias in any of the sessions? If so, please explain:    
Did the activity comply with the Code of Ethics for parties involved in continuing medical education?
Were there any topics you think should have been addressed?  Any recommendations for future sessions?
Please share any additional comments:
Thank you!